WBL Biotech

WBL Biotech is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for inflammatory and autoimmune diseases. The company leverages its proprietary drug discovery platform to target key pathways in the immune system, with a particular emphasis on dermatology and respiratory conditions. Its lead programs include small molecule inhibitors and monoclonal antibodies designed to provide superior efficacy and safety profiles compared to existing treatments. WBL Biotech aims to address significant unmet medical needs in chronic inflammatory disorders through precision medicine and advanced molecular engineering.